by Clinical Neuropsychologist | Thursday, February 6, 2025 | Neuroimaging
ABSTRACT Background and Purpose Right-to-left shunt (RLS), usually related to a patent foramen ovale (PFO), is an important cause of cryptogenic stroke (CS) in young patients. Transcranial Doppler (TCD) with an agitated saline bubble study is a highly sensitive...
by Clinical Neuropsychologist | Tuesday, February 4, 2025 | Neuroimaging
ABSTRACT Background and Purpose This study investigated the neural mechanisms underlying Parkinson’s disease (PD) subtypes—tremor dominant (TD) and postural instability gait difficulty (PIGD)—by analyzing regional homogeneity (ReHo) values from resting-state...
by Clinical Neuropsychologist | Tuesday, February 4, 2025 | Neuroimaging
ABSTRACT Background and Purpose Silent brain infarcts (SBIs), which manifest as dot-like lesions on diffusion-weighted imaging (DWI) after endovascular procedures, are associated with an increased risk of stroke, dementia, and cognitive decline. We aimed to identify...
by Clinical Neuropsychologist | Friday, January 24, 2025 | Neuroimaging
ABSTRACT Intracranial pressure (ICP) monitoring is a cornerstone of neurocritical care in managing severe brain injury. However, current invasive ICP monitoring methods carry significant risks, including infection and intracranial hemorrhage, and are contraindicated...
by Clinical Neuropsychologist | Wednesday, January 22, 2025 | Neuroimaging
ABSTRACT Background and Purpose The central vein sign (CVS) is a diagnostic imaging biomarker for multiple sclerosis (MS). FLAIR* is a combined MRI contrast that provides high conspicuity for CVS at 3 Tesla (3T), enabling its sensitive and accurate detection in...
by Clinical Neuropsychologist | Tuesday, January 21, 2025 | Neuroimaging
ABSTRACT Background and purpose Prolonged length of stay (LOS) following a stroke is associated with unfavorable clinical outcomes. Factors predicting LOS in medium vessel occlusion (MeVO), impacting up to 40% of acute ischemic stroke (AIS) cases, remain...
